← Leaderboards
Dolly Ann Padovani-Claudio
Vanderbilt University Medical Center
$2,239,097
Attributed
$3,381,697
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,381,697 · 3
By mechanism
R01$2,398,467 · 2
K08$983,230 · 1
Top collaborators
- Jennifer Below2 shared
- Susan P Fisher-Hoch2 shared
- Kari E North2 shared
Most similar at Vanderbilt University Medical Center
Same institution · by research overlap
- Lorraine B Ware$25,185,641
Others in their field
Other Emerging Leaders on “Complex”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$58,784,651
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$41,535,815
- John Hobbs · Suny At Stony Brook$41,239,084
Research focus
ComplexVisionInflammatoryRetinal DiseasesDiabeticAffectNovel TherapeuticsMetabolicObesityIl8ra GeneInterleukin-1 BetaLigandsAge Related Macular DegenerationNeurogliaFatty AcidsIl8rb GeneDiabetes MellitusBlindnessClinical TrialsEndothelial CellsFunctional DisorderGenesCytokineDiabetic Retinopathy
Grant awards (9)
Integrative multi-omics for discovery of molecular pathways associated with diabetic retinopathy$741,232
R01 · FY2025 · EY · contact PI
Biobank phenotyping tools for improved understanding and management of eye diseases and disparities$437,500
R01 · FY2025 · EY · contact PI
Integrative multi-omics for discovery of molecular pathways associated with diabetic retinopathy$782,235
R01 · FY2024 · EY · contact PI
Biobank phenotyping tools for improved understanding and management of eye diseases and disparities$437,500
R01 · FY2024 · EY · contact PI
Novel Therapeutic Strategies for Retinal Vascular Inflammation and Angiogenesis in Diabetic Retinopathy.$196,646
K08 · FY2022 · EY · contact PI
Novel Therapeutic Strategies for Retinal Vascular Inflammation and Angiogenesis in Diabetic Retinopathy.$196,646
K08 · FY2021 · EY · contact PI
Novel Therapeutic Strategies for Retinal Vascular Inflammation and Angiogenesis in Diabetic Retinopathy.$196,646
K08 · FY2020 · EY · contact PI
Novel Therapeutic Strategies for Retinal Vascular Inflammation and Angiogenesis in Diabetic Retinopathy.$196,646
K08 · FY2019 · EY · contact PI
Novel Therapeutic Strategies for Retinal Vascular Inflammation and Angiogenesis in Diabetic Retinopathy.$196,646
K08 · FY2018 · EY · contact PI